ID   XWLC-05
AC   CVCL_IQ71
SY   XuanWei Lung Cancer-05
DR   Wikidata; Q54995085
RX   PubMed=17222362;
RX   PubMed=29115620;
CC   Population: Chinese.
CC   Doubling time: 32.8 hours (PubMed=17222362).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
RX   PubMed=17222362;
RA   Yan, Feng-Cai
RA   Wang, Qin-Qin
RA   Ruan, Yong-Hua
RA   Ma, Li-Ju
RA   Jia, Jian-Tao
RA   Jin, Ke-Wei
RT   "Establishment and biological characteristics of lung cancer cell line
RT   XWLC-05.";
RL   Ai Zheng 26:21-25(2007).
//
RX   PubMed=29115620; DOI=10.3892/mmr.2017.7959; PMCID=PMC5780170;
RA   Gong, Quan
RA   Liu, Chao
RA   Wang, Cun-De
RA   Zhuang, Li
RA   Zhang, Li-Juan
RA   Wang, Xi-Cai
RT   "Effect of silencing TEM8 gene on proliferation, apoptosis, migration
RT   and invasion of XWLC-05 lung cancer cells.";
RL   Mol. Med. Rep. 17:911-917(2018).
//